EP300 and hepatocellular carcinoma: Moreover, hepatocellular carcinoma and PCa with gain of HLA, PSMB, and TAP genes, possibly due to chromosome 6p amplification (62), show higher frequency of CBP/EP300 loss, which may allow them to undergo immune evasion.